Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Odonate Therapeutics, Inc. (ODTC) had Earnings per Share (EPS) (Basic) of $-3700.00 for the most recently reported fiscal quarter, ending 2021-09-30.
| Income Statement Financials | |
-- |
|
$-14.00M |
|
-- |
|
-- |
|
$14.02M |
|
$-14.02M |
|
$0.02M |
|
$-14.00M |
|
$-14.00M |
|
$-14.00M |
|
$-14.00M |
|
$-14.00M |
|
$-14.00M |
|
$-14.02M |
|
$-13.90M |
|
0.00M |
|
0.00M |
|
|
Earnings per Share (EPS) (Basic) |
$-3700.00 |
$-3700.00 |
|
| Balance Sheet Financials | |
$99.58M |
|
$1.83M |
|
$6.19M |
|
$105.77M |
|
$30.30M |
|
-- |
|
$4.11M |
|
$34.40M |
|
$71.37M |
|
$71.37M |
|
$71.37M |
|
0.00M |
|
| Cash Flow Statement Financials | |
$-63.04M |
|
$-0.03M |
|
$0.82M |
|
$157.98M |
|
$95.74M |
|
$-62.24M |
|
$4.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-63.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.61% |
|
-19.61% |
|
-13.23% |
|
-19.61% |
|
$0.02M |
|
$-0.02M |
|
$-0.02M |
|